DermaGenoma

DermaGenoma is a molecular dermatology company founded by leading researchers and experts in genetics and dermatology. The company is dedicated to researching and developing novel diagnostics and prescription treatments for skin conditions based on individual genetic makeup. DermaGenoma launched the AcneDX genetic test for antibiotic response in the United States, which evaluates the antibiotic susceptibility of Cutibacterium acnes using sebum samples.